Medscape Medical News
- FDA Approves First Drug for Eosinophilic Esophagitis
- Alert Tirzepatide (Mounjaro) Gets FDA Approval for Type 2 Diabetes
- Alert FDA Approves Medtronic's Onyx Frontier Drug-Eluting Stent
- Alert FDA Approves Oral Form of ALS Drug Edaravone
- Alert FDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer
- Alert FDA Approves Two Vonoprazan Therapies for H pylori Eradication
- Alert FDA Approves New Drug for Wilson's Disease
- Alert Upadacitinib Earns FDA Approval for Ankylosing Spondylitis
- Alert FDA Okays First-in-Class Treatment for Obstructive HCM
- Alert FDA Approves Oteseconazole for Chronic Yeast Infections
- Alert FDA Approves Fitbit's AFib-Detection Software
- Alert FDA Okays First Sublingual Med for Agitation in Schizophrenia, BD
- Alert FDA Approves Leadless, Single-Chamber Pacemaker System
- Alert FDA Approves Software to Semiautomate Anesthesia Delivery
- Alert FDA Okays New Med for Lennox-Gastaut Syndrome
- Alert FDA Okays Semaglutide Higher Dose, 2 mg/Week, for Type 2 Diabetes
- Alert FDA Approves Cabenuva Initiation Without Oral Lead-in
- Alert FDA Approves New Radioligand Therapy and Diagnostic for mCRPC
- Alert FDA Approves New Immunotherapy Combo for Melanoma
- Alert FDA Approves Upadacitinib for Ulcerative Colitis